Diagnostic Strategy for Females Suspected of Fabry Disease

18. August 2020

Fabry disease (FD) is a X-linked inherited disorder where deficiency of the α-Galactosidase A (α-Gal A) enzyme causes Globotriaosylceramide...

Read more

Novel diagnostics for Rare Disorders: Fabry in females, presented at WorldSymposium

7. March 2018

The parallel measurement of lyso-GL-3 (lyso-Gb3) for Fabry disease is of high importance particularly for potential female Fabry patients,...

Read more

Genotype, phenotype and disease severity reflected by serum LysoGb3 levels in patients with Fabry disease

5. July 2017

Background: Fabry disease (FD) is a rare X-linked lysosomal storage disease caused by mutations in the α-galactosidase A (GLA)...

Read more

Metabolic progression to clinical phenotype in classic Fabry disease

3. January 2017

Background: Fabry disease is an X-linked lysosomal storage disorder due to α-galactosidase A (α-Gal A) deficiency. Clinical onset of...

Read more

Plasma LysoGb3: A useful biomarker for the diagnosis and treatment of Fabry disease heterozygotes

19. October 2016

Background: Fabry disease (FD) is a rare X-linked lysosomal storage disorder due to mutations in the a-galactosidase A gene (GLA)...

Read more